Nasdaq Grants Sequenom Inc.'s Request For Exception To Comply With Listing Requirement

SAN DIEGO, April 26 /PRNewswire-FirstCall/ -- Sequenom, Inc. announced today that it has received a letter from the Nasdaq Listing Qualifications Panel of The Nasdaq Stock Market, Inc. notifying the Company that it has been granted an extension until June 15, 2006 to comply with Nasdaq's minimum closing bid price requirement of $1.00 per share for ten consecutive trading days. This notice follows the Company's hearing before the Panel that took place on April 12, 2006.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040415/SQNMLOGO )

"Obviously we are delighted with the Panel's consideration of Sequenom's position and the outcome of the hearing, and we look forward to our upcoming annual shareholder meeting," said Harry Stylli, MBA, Ph.D., President and Chief Executive Officer of Sequenom.

Provided that the Company's stockholders approve amendment to the Company's Certificate of Incorporation and authorize the Company's Board of Directors to implement a reverse stock split at the Company's upcoming annual shareholder meeting scheduled for May 31, 2006, this extension should enable the Company to achieve compliance with Nasdaq listing requirements and remain listed on The Nasdaq Stock Market. However, until Nasdaq renders a final determination that the Company has regained compliance with the $1.00 bid price requirement, there can be no assurances regarding the Company's continued listing on Nasdaq. Additional information may be found in the Company's Proxy Statement for its Annual Meeting of Stockholders set forth on Schedule 14A filed with the Securities and Exchange Commission on April 24, 2006.

Except for the historical information contained herein, the matters set forth in this press release, including without limitation statements regarding the Company's upcoming annual shareholder meeting, approval of amendments to the Company's Certificate of Incorporation, authorization to implement a reverse stock split, and the Company's ability to achieve compliance with Nasdaq listing requirements and remain listed on The Nasdaq Stock Market, are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These forward- looking statements are subject to risks and uncertainties that may cause actual results to differ materially, including the risks and uncertainties associated with stockholder approval, the Company's share price, and the review, if any, of the Panel's decision by the Nasdaq Listing and Hearing Review Council, and other risks and uncertainties detailed from time to time in the Company's SEC filings, including the Company's Annual Report on Form 10-K for the year ended December 31, 2005, and most recent Proxy Statement on Schedule 14A. These forward-looking statements are based on current information that is likely to change and speak only as of the date hereof.

Stockholders of the Company are urged to read the Company's proxy statement for its 2006 annual meeting of stockholders filed with the SEC which includes proposals referred to in this press release. The Company and its executive officers and directors may be deemed to be participants in the solicitation of proxies from stockholders of the Company with respect to such proposals, the Company's pending financing, and other matters. Information regarding such officers and directors is included in the Company's proxy statement for its 2006 annual meeting of stockholders or in other current or periodic reports filed with the SEC. Stockholders may obtain a free copy of the proxy statement and other documents filed with the SEC at the SEC's website at http://www.sec.gov. The proxy statement and these other documents may also be obtained for free from the Company by contacting: Investor Relations, Sequenom, Inc., 3595 John Hopkins Court, San Diego, CA 92121, (858) 202-9000.

CONTACT: Clarke Neumann, Investor Relations of Sequenom, Inc.,+1-858-202-9206, cneumann@sequenom.com

Web site: http://www.sequenom.com/